FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3028273802> ?p ?o ?g. }

• W3028273802 endingPage "1743" @default.
• W3028273802 startingPage "1736" @default.
• W3028273802 abstract "Abstract Background Tisagenlecleucel demonstrated a high rate of durable response in adult patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL) in the pivotal global phase 2 JULIET study. Here, we report the efficacy and safety of tisagenlecleucel in the Japanese subgroup. Methods JULIET (NCT02445248) is a single-arm, open-label, multicenter, phase 2 study involving adult patients with r/r DLBCL who either relapsed after or were ineligible for autologous stem cell transplant. Primary endpoint was best overall response rate (ORR; complete response [CR] + partial response [PR]) as judged by an independent review committee. Results In Japan, of 17 patients enrolled, 9 were infused with tisagenlecleucel and completed ≥ 3 months of follow-up. Best ORR was 77.8% (7/9; 95% confidence interval, 40.0–97.2), with 5 patients (55.6%) in CR and 2 (22.2%) in PR. Cytokine release syndrome (CRS) occurred in 6 patients (66.7%), with grade 3 CRS in 2 patients (Penn grading scale). Two patients received tocilizumab. Two deaths (22.2%) occurred more than 30 days after tisagenlecleucel infusion due to disease progression, neither of which were related to tisagenlecleucel. Conclusion Tisagenlecleucel showed a high best ORR with a manageable safety profile, thus offering a new treatment option in selected Japanese patients with r/r DLBCL." @default.
• W3028273802 created "2020-05-29" @default.
• W3028273802 creator A5010046270 @default.
• W3028273802 creator A5012284856 @default.
• W3028273802 creator A5026278665 @default.
• W3028273802 creator A5027118202 @default.
• W3028273802 creator A5028379115 @default.
• W3028273802 creator A5041455800 @default.
• W3028273802 creator A5060306792 @default.
• W3028273802 creator A5080282516 @default.
• W3028273802 date "2020-05-24" @default.
• W3028273802 modified "2023-10-14" @default.
• W3028273802 title "Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma" @default.
• W3028273802 cites W2020789296 @default.
• W3028273802 cites W2133201432 @default.
• W3028273802 cites W2145560894 @default.
• W3028273802 cites W2145985838 @default.
• W3028273802 cites W2595092734 @default.
• W3028273802 cites W2744261860 @default.
• W3028273802 cites W2773804840 @default.
• W3028273802 cites W2775369717 @default.
• W3028273802 cites W2892326722 @default.
• W3028273802 cites W2903062212 @default.
• W3028273802 cites W2985861192 @default.
• W3028273802 doi "https://doi.org/10.1007/s10147-020-01699-6" @default.
• W3028273802 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7441082" @default.
• W3028273802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32448949" @default.
• W3028273802 hasPublicationYear "2020" @default.
• W3028273802 type Work @default.
• W3028273802 sameAs 3028273802 @default.
• W3028273802 citedByCount "13" @default.
• W3028273802 countsByYear W30282738022021 @default.
• W3028273802 countsByYear W30282738022022 @default.
• W3028273802 countsByYear W30282738022023 @default.
• W3028273802 crossrefType "journal-article" @default.
• W3028273802 hasAuthorship W3028273802A5010046270 @default.
• W3028273802 hasAuthorship W3028273802A5012284856 @default.
• W3028273802 hasAuthorship W3028273802A5026278665 @default.
• W3028273802 hasAuthorship W3028273802A5027118202 @default.
• W3028273802 hasAuthorship W3028273802A5028379115 @default.
• W3028273802 hasAuthorship W3028273802A5041455800 @default.
• W3028273802 hasAuthorship W3028273802A5060306792 @default.
• W3028273802 hasAuthorship W3028273802A5080282516 @default.
• W3028273802 hasBestOaLocation W30282738021 @default.
• W3028273802 hasConcept C121332964 @default.
• W3028273802 hasConcept C121608353 @default.
• W3028273802 hasConcept C126322002 @default.
• W3028273802 hasConcept C142424586 @default.
• W3028273802 hasConcept C143998085 @default.
• W3028273802 hasConcept C203092338 @default.
• W3028273802 hasConcept C2777701055 @default.
• W3028273802 hasConcept C2778559949 @default.
• W3028273802 hasConcept C2779338263 @default.
• W3028273802 hasConcept C2780850621 @default.
• W3028273802 hasConcept C31760486 @default.
• W3028273802 hasConcept C3875195 @default.
• W3028273802 hasConcept C535046627 @default.
• W3028273802 hasConcept C71924100 @default.
• W3028273802 hasConcept C87355193 @default.
• W3028273802 hasConcept C90924648 @default.
• W3028273802 hasConceptScore W3028273802C121332964 @default.
• W3028273802 hasConceptScore W3028273802C121608353 @default.
• W3028273802 hasConceptScore W3028273802C126322002 @default.
• W3028273802 hasConceptScore W3028273802C142424586 @default.
• W3028273802 hasConceptScore W3028273802C143998085 @default.
• W3028273802 hasConceptScore W3028273802C203092338 @default.
• W3028273802 hasConceptScore W3028273802C2777701055 @default.
• W3028273802 hasConceptScore W3028273802C2778559949 @default.
• W3028273802 hasConceptScore W3028273802C2779338263 @default.
• W3028273802 hasConceptScore W3028273802C2780850621 @default.
• W3028273802 hasConceptScore W3028273802C31760486 @default.
• W3028273802 hasConceptScore W3028273802C3875195 @default.
• W3028273802 hasConceptScore W3028273802C535046627 @default.
• W3028273802 hasConceptScore W3028273802C71924100 @default.
• W3028273802 hasConceptScore W3028273802C87355193 @default.
• W3028273802 hasConceptScore W3028273802C90924648 @default.
• W3028273802 hasFunder F4320310388 @default.
• W3028273802 hasFunder F4320332736 @default.
• W3028273802 hasIssue "9" @default.
• W3028273802 hasLocation W30282738021 @default.
• W3028273802 hasLocation W30282738022 @default.
• W3028273802 hasLocation W30282738023 @default.
• W3028273802 hasOpenAccess W3028273802 @default.
• W3028273802 hasPrimaryLocation W30282738021 @default.
• W3028273802 hasRelatedWork W2133349049 @default.
• W3028273802 hasRelatedWork W2305782972 @default.
• W3028273802 hasRelatedWork W2620353104 @default.
• W3028273802 hasRelatedWork W2789668336 @default.
• W3028273802 hasRelatedWork W2952224846 @default.
• W3028273802 hasRelatedWork W3028273802 @default.
• W3028273802 hasRelatedWork W3146579184 @default.
• W3028273802 hasRelatedWork W3182090251 @default.
• W3028273802 hasRelatedWork W4200446577 @default.
• W3028273802 hasRelatedWork W4298008142 @default.
• W3028273802 hasVolume "25" @default.
• W3028273802 isParatext "false" @default.
• W3028273802 isRetracted "false" @default.
• W3028273802 magId "3028273802" @default.

• next